Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
42
pubmed:dateCreated
2000-11-9
pubmed:abstractText
In A549 human lung adenocarcinoma cells, we found that TNF-alpha and several commonly used chemotherapeutic agents upregulated the expression of Bcl-x and/or Bfl-1/A1 through an NF-kappaB-dependent pathway. While parental A549 cells were resistant to the cytotoxic effects of both TNF-alpha and chemotherapy agents, NF-kappaB-blocked A549 cells were sensitized to both. Expression of either Bcl-x or Bfl-1/A1 in the NF-kappaB-deficient cells at physiological levels provided differential protection against TNF-alpha and chemotherapeutic treatment. These studies provide a potential mechanism for the phenomenon of chemotherapy-induced chemoresistance, and also reveal a potential strategy by which chemoresistance can be overcome.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/BCL2-related protein A1, http://linkedlifedata.com/resource/pubmed/chemical/BCL2L1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Doxycycline, http://linkedlifedata.com/resource/pubmed/chemical/I-kappa B Proteins, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappaB inhibitor alpha, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Neoplasm, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/bcl-X Protein
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0950-9232
pubmed:author
pubmed:issnType
Print
pubmed:day
5
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4936-40
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11039911-Adenocarcinoma, pubmed-meshheading:11039911-Antineoplastic Agents, pubmed-meshheading:11039911-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:11039911-DNA-Binding Proteins, pubmed-meshheading:11039911-Doxycycline, pubmed-meshheading:11039911-Drug Resistance, Neoplasm, pubmed-meshheading:11039911-Gene Expression Regulation, Neoplastic, pubmed-meshheading:11039911-Humans, pubmed-meshheading:11039911-I-kappa B Proteins, pubmed-meshheading:11039911-Lung Neoplasms, pubmed-meshheading:11039911-NF-kappa B, pubmed-meshheading:11039911-Neoplasm Proteins, pubmed-meshheading:11039911-Protein Biosynthesis, pubmed-meshheading:11039911-Proteins, pubmed-meshheading:11039911-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:11039911-RNA, Messenger, pubmed-meshheading:11039911-RNA, Neoplasm, pubmed-meshheading:11039911-Receptors, Tumor Necrosis Factor, pubmed-meshheading:11039911-Recombinant Fusion Proteins, pubmed-meshheading:11039911-Transfection, pubmed-meshheading:11039911-Tumor Cells, Cultured, pubmed-meshheading:11039911-Tumor Necrosis Factor-alpha, pubmed-meshheading:11039911-bcl-X Protein
pubmed:year
2000
pubmed:articleTitle
Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-kappaB inhibition.
pubmed:affiliation
Department of Microbiology and Molecular Genetics, Jonsson Comprehensive Cancer Center and Molecular Biology Institute, University of California Los Angeles, 90095, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S.